Description
The U.S. Food and Drug Administration (FDA) is seeking information from potential vendors who can provide a Preventive and Unlimited Corrective Repair service agreement for a Surface Plasmon Resonance (SPR) Biacore T200 instrument. The agreement would include annual preventive maintenance, unlimited on-site corrective maintenance and emergency repairs, priority emergency response, and proprietary software and firmware support. The vendor must be able to meet the minimum performance requirements, which include providing a comprehensive full-system diagnostic, exchanging critical wear-and-tear components, and providing unlimited priority access to the Original Equipment Manufacturer (OEM) online support center.
• The service agreement would be for a Base year plus two option years, with the following anticipated period of performance dates: Base Year: 08/30/2026 – 08/29/2027, Option Year 1: 08/30/2027 – 08/29/2028, Option Year 2: 08/30/2028 – 08/29/2029.
• The maintenance agreement for this instrument expired on 02/24/2025, so a new service agreement is needed as soon as possible.
• The equipment is located at the Center for Biologics Evaluation and Research (CBER) in Silver Spring, MD.
• Responses to this Sources Sought shall unequivocally demonstrate that the respondent is regularly engaged in the sale of same or substantially similar services.